Jim Simons Genetic Technologies LTD Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$0.0 - $0.0 $0 - $0	-106,164 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.0 - $0.0 $0 - $0	-56,939 Reduced 34.91%	106,164 $242,000
Q1 2020 May 14, 2020	BUY	$0.0 - $0.0 $0 - $0	32,791 Added 25.16%	163,103 $321,000
Q4 2019 Feb 13, 2020	BUY	$0.0 - $0.0 $0 - $0	17,615 Added 15.63%	130,312 $259,000
Q3 2019 Nov 13, 2019	BUY	$0.0 - $0.0 $0 - $0	112,697 New	112,697 $214,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.